Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1688

1.

Skeletal and extra-skeletal actions of vitamin D: Current evidence and outstanding questions.

Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J.

Endocr Rev. 2018 Oct 12. doi: 10.1210/er.2018-00126. [Epub ahead of print]

PMID:
30321335
2.

Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis.

Ahmad I, Jafar T, Mahdi F, Arshad M, Das SK, Waliullah S, Mahdi AA.

Indian J Clin Biochem. 2018 Oct;33(4):429-437. doi: 10.1007/s12291-017-0706-x. Epub 2017 Oct 28.

PMID:
30319189
3.

[The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes].

Wysoczańska-Klaczyńska A, Ślęzak A, Hetman M, Barg E.

Pediatr Endocrinol Diabetes Metab. 2018;24(2):96-105. doi: 10.18544/PEDM-24.02.0108. Review. Polish.

PMID:
30300431
4.

Mineral bone disorders in chronic kidney disease.

Hou YC, Lu CL, Lu KC.

Nephrology (Carlton). 2018 Oct;23 Suppl 4:88-94. doi: 10.1111/nep.13457. Review.

PMID:
30298663
5.

[Rickets/Osteomalacia. The function and mechanism of vitamin D action.]

Makishima M.

Clin Calcium. 2018;28(10):1319-1326. doi: CliCa181013191326. Japanese.

PMID:
30269113
6.

Evaluation of Association of Vitamin D Receptor Genetic Polymorphism with Severe Chronic Periodontitis in an Ethnic Tamilian Population.

Ratheesh V, Subramanian S, Prakash PSG, Victor DJ.

Genet Test Mol Biomarkers. 2018 Sep 20. doi: 10.1089/gtmb.2018.0190. [Epub ahead of print]

PMID:
30234384
7.

Vitamin D, the gut microbiome and inflammatory bowel disease.

Tabatabaeizadeh SA, Tafazoli N, Ferns GA, Avan A, Ghayour-Mobarhan M.

J Res Med Sci. 2018 Aug 23;23:75. doi: 10.4103/jrms.JRMS_606_17. eCollection 2018. Review.

8.

Association between Vitamin D Deficiency and Single Nucleotide Polymorphisms in the Vitamin D Receptor and GC Genes and Analysis of Their Distribution in Mexican Postmenopausal Women.

Rivera-Paredez B, Macías N, Martínez-Aguilar MM, Hidalgo-Bravo A, Flores M, Quezada-Sánchez AD, Denova-Gutiérrez E, Cid M, Martínez-Hernández A, Orozco L, Quiterio M, Flores YN, Salmerón J, Velázquez-Cruz R.

Nutrients. 2018 Aug 27;10(9). pii: E1175. doi: 10.3390/nu10091175.

9.

Vitamin D in Cardiovascular Disease.

Nitsa A, Toutouza M, Machairas N, Mariolis A, Philippou A, Koutsilieris M.

In Vivo. 2018 Sep-Oct;32(5):977-981. doi: 10.21873/invivo.11338. Review.

PMID:
30150419
10.

Genetic determinants of vitamin D-related disorders; focus on vitamin D receptor.

Abouzid M, Karazniewicz-Lada M, Glowka F.

Curr Drug Metab. 2018 Jul 23. doi: 10.2174/1389200219666180723143552. [Epub ahead of print]

PMID:
30039758
11.

Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes.

Nishikawa M, Yasuda K, Takamatsu M, Abe K, Nakagawa K, Tsugawa N, Hirota Y, Tanaka K, Yamashita S, Ikushiro S, Suda T, Okano T, Sakaki T.

J Steroid Biochem Mol Biol. 2018 Jul 18. pii: S0960-0760(18)30288-7. doi: 10.1016/j.jsbmb.2018.07.012. [Epub ahead of print]

PMID:
30031146
12.

Variability of contribution of vitamin D receptor gene polymorphisms to outcome of HLA-matched sibling allogeneic bone marrow transplantation.

Kamel AM, El-Fishawi S, Rasekh EO, Radwan ER, Zeidan A, El-Said A, Zaky AH, Abdelfattah M, Refaat A, Abdelfattah R.

Leuk Lymphoma. 2018 Jul 4:1-10. doi: 10.1080/10428194.2018.1459608. [Epub ahead of print]

PMID:
29972092
13.

Vitamin D in the Middle East and North Africa.

Chakhtoura M, Rahme M, Chamoun N, El-Hajj Fuleihan G.

Bone Rep. 2018 Mar 17;8:135-146. doi: 10.1016/j.bonr.2018.03.004. eCollection 2018 Jun.

14.

Association of Vitamin D Receptor Gene Variation With Osteoporosis Risk in Belarusian and Lithuanian Postmenopausal Women.

Marozik PM, Tamulaitiene M, Rudenka E, Alekna V, Mosse I, Rudenka A, Samokhovec V, Kobets K.

Front Endocrinol (Lausanne). 2018 Jun 5;9:305. doi: 10.3389/fendo.2018.00305. eCollection 2018.

15.
16.

Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.

Friedl C, Zitt E.

Drug Des Devel Ther. 2018 Jun 1;12:1589-1598. doi: 10.2147/DDDT.S134103. eCollection 2018. Review.

17.

Evaluation of prevalence, biochemical profile, and drugs associated with chronic kidney disease-mineral and bone disorder in 11 dialysis centers.

Abrita RR, Pereira BDS, Fernandes NDS, Abrita R, Huaira RMNH, Bastos MG, Fernandes NMDS.

J Bras Nefrol. 2018 Jan-Mar;40(1):26-34. doi: 10.1590/2175-8239-JBN-3527. Epub 2018 May 7. English, Portuguese.

18.

Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients.

Tanaka M, Komaba H, Fukagawa M.

Ther Apher Dial. 2018 Jun;22(3):242-245. doi: 10.1111/1744-9987.12685. Epub 2018 May 16. Review.

PMID:
29767854
19.

Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method.

Ito E, Inaguma D, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y.

Clin Exp Nephrol. 2018 May 10. doi: 10.1007/s10157-018-1584-0. [Epub ahead of print]

PMID:
29748907
20.

Supplemental Content

Loading ...
Support Center